NCT06777472

Clinical Study of Lung-benefiting Moxibustion Reduce Exacerbations of Asthma

Clinical Study on Reducing Exacerbations of Asthma by Lung-benefiting Moxibustion Based on "Winter Disease Cured in Summer"

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 384 (estimated)
• Sponsor: Cuiling Feng · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

For patients with poor asthma control, on the basis of treatment guided by GINA guidelines, lung-benefiting moxibustion treatment will be given, and it will be applied 10 days before "early onset", once every 10 days, and the follow-up was 45 weeks, 1 cycle per year, for 2 consecutive cycles (2 years). The annual number of flare-up of asthma patients will be used as the main outcome index to evaluate the clinical effect of lung-benefiting moxibustion on reducing exacerbations of asthma. By observing immunoglobulin, T cell subsets and other indicators, the advantage population and mechanism of moxibustion in treating patients with poor asthma control will be clarified.

Conditions

• Asthma

Interventions

Type	Name	Description
OTHER	lung-benefiting moxibustion	A kind of external treatment，the treatment theory is to treat winter diseases in summer.
DRUG	The specific drug comes from "GINA (2024)"	Refer to "GINA (2024)".

Timeline

• Start date: 2025-07-01
• Primary completion: 2026-09-01
• Completion: 2027-08-01
• First posted: 2025-01-15
• Last updated: 2025-01-15